Global Tissue Diagnostic Market
is expected to reach USD 6.4 billion by 2022, according to a new study by Grand
View Research Inc. Tissue diagnostic, due to its ability to detect cancer at an
early stage, is expected to witness significant growth over the forecast
period.
Increasing incidences of breast cancer, rising geriatric population
base and the growing demand for personalized medicines are high impact
rendering drivers of the tissue diagnostics market. Furthermore, improving
healthcare infrastructure, increasing demand for safe and cost effective
treatment and rising focus of major market players on emerging economies such
as India and China are likely to propel market growth. Technological
advancement occurring in the field of tissue diagnostics is expected to lead
towards the availability of better option for healthcare professionals and the
patients. Tissue diagnostic procedures encompass a broad array of technologies
designed to revolutionize the cancer diagnosis process and provide apt
molecular information. Tissue diagnostic detects the presence of malignant
cells by performing microscopic study of the involved tissue. This
investigation is considered to be vital for any type of cancer in order to
decide the most effective treatment line.
In depth research report on Tissue Diagnostic Market
Further key findings from the study suggest:
·
Immunohistochemistry (IHC) is
identified as the most lucrative sub segment of the tissue diagnostic market
majorly owing to increasing incidences of cancer diagnostic
·
The tissue based breast cancer
diagnostic segment accounted for the largest market share in 2014. Rising
alcohol consumption, lifestyle associated changes and growing geriatric
population are some factors expected to drive segment growth over the forecast
period.
·
North America accounted for over
40.0% of the tissue diagnostic market in 2014 on account of high usage rates of
technologically advanced products. Rising patient awareness level and the
presence of accessible healthcare infrastructure is also expected to contribute
towards healthy regional market growth.
·
Asia Pacific is expected to
witness the fastest growth over the forecast period. Rapid economic development
and the consequent improvement of the healthcare infrastructure is expected to
help manufacturers capitalize on the available opportunities in the form of
unmet medical needs. Presence of sophisticated healthcare facilities in the
developed markets of Japan and Australia is also expected to boost usage rates
over the forecast period.
·
Key players of the tissue
diagnostic market include Roche Diagnostics, Cell Signaling Technologies,
Becton Dickinson & Company, Agilent Technologies, Abbott Laboratories, GE
Healthcare, Thermo Fisher Scientific, Johnson & Johnson and Danaher
Corporation.
For the purpose of this study,
Grand View Research has segmented the global tissue diagnostic market on the
basis of products, technology, application, end-use and region:
Global Tissue Diagnostic Product Outlook (Revenue, USD
Million, 2012 - 2022)
·
Instruments
·
Accessories
Global Tissue Diagnostic Technology Outlook (Revenue, USD
Million, 2012 - 2022)
·
Immunohistochemistry (IHC)
·
In Situ Hybridization
·
Special Staining
·
Digital Pathology and Workflow
Global Tissue Diagnostic Application Outlook (Revenue, USD
Million, 2012 - 2022)
·
Lymphoma
·
Breast Cancer
·
Gastric Cancer
·
Prostate Cancer
·
Non Small Cell Lung Cancer
Global Tissue Diagnostic End-use Outlook (Revenue, USD
Million, 2012 - 2022)
·
Hospitals
·
Contract Research Organization
(CRO)
·
Pharmaceutical Organizations
·
Research Laboratories
Tissue Diagnostic Regional Outlook (Revenue, USD Million,
2012 - 2022)
·
North America
·
U.S.
·
Canada
·
Rest of North America
·
Europe
·
Germany
·
France
·
Spain
·
Rest of Europe
·
Asia Pacific
·
Japan
·
China
·
India
·
Rest of Asia Pacific
·
Latin America
·
Brazil
·
Mexico
·
Rest of Latin America
·
Middle East and Africa (MEA)
·
South Africa
·
Rest of Middle East and Africa
Browse more research reports of this category:
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and energy.
For more market analysis reports, please visit: http://www.grandviewresearch.com/
No comments:
Post a Comment